Literature DB >> 21992789

Treatment of chronic intractable atypical facial pain using peripheral subcutaneous field stimulation.

Alexander E Yakovlev1, Beth E Resch.   

Abstract

INTRODUCTION: Atypical facial pain (ATFP) is challenging to manage and there are few proven therapies available. We present a case report describing application of peripheral subcutaneous field stimulation (PSFS) to a patient with chronic intractable ATFP which conventional treatment failed to ameliorate.
METHODS: The patient underwent an uneventful PSFS trial with percutaneous placement of two temporary eight-electrode leads (Medtronic Inc, Minneapolis, MN, USA) placed subdermally over the left mandible.
RESULTS: After experiencing excellent pain relief over the next two days, the patient was implanted with permanent leads and rechargeable generator two and a half weeks later and reported sustained pain relief at 12-month follow-up visit. DISCUSSION: Peripheral subcutaneous field stimulation provides an effective treatment option for patients suffering from chronic ATFP who have failed conservative treatment. PSFS may provide pain relief with advantages over conservative treatments and more invasive techniques.
CONCLUSION: Peripheral subcutaneous field stimulation offers an alternative treatment option to select patients with intractable ATFP.
© 2010 International Neuromodulation Society.

Entities:  

Year:  2010        PMID: 21992789     DOI: 10.1111/j.1525-1403.2009.00249.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  3 in total

Review 1.  Peripheral neuromodulation and headaches: history, clinical approach, and considerations on underlying mechanisms.

Authors:  Ken L Reed
Journal:  Curr Pain Headache Rep       Date:  2013-01

2.  Use of botulinum toxin injections to treat peripheral stimulator induced facial muscle twitching: a case report.

Authors:  Terrence L Trentman; Jillian A Maloney; Christopher S Wie; Alanna M Rebecca; David M Rosenfeld
Journal:  Springerplus       Date:  2015-11-04

3.  Concordant occipital and supraorbital neurostimulation therapy for hemiplegic migraine; initial experience; a case series.

Authors:  Ken L Reed; Kelly R Will; Frank Conidi; Robert Bulger
Journal:  Neuromodulation       Date:  2015-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.